AwardedCzechiaGoodsCZK 72,142,000
LP k léčbě plicní arteriální hypertenze (PAH) XIII.
- Published
- Published 11 July 2025
- Deadline
- Closed 12 August 2025
Overview
Předmětem veřejné zakázky jsou dodávky léčivých přípravků s obsahem účinných látek ambrisentan (ATC C02KX02), bosentan (ATC C02KX01), sildenafil (ATC G04BE03), tadalafil (ATC G04BE08) a macitentan (ATC C02KX04) pro léčbu pacientů ve schválené indikaci plicní arteriální hypertenze (PAH) dle SPC platného ke dni podání nabídek.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 72,142,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 11 July 2025
- Deadline
- Closed
Medicinal products for the cardiovascular system
Award outcome
- Awarded value
- CZK 21,306,510
- Award date
- 20 August 2025
- Contract period
- 21 September 2025 → 31 August 2029
- Alliance Healthcare s.r.o.
- Janssen-Cilag s.r.o.
- PROMEDICA PRAHA GROUP, a.s.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
24 September 2025
Contract Notice
11 July 2025
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.